ADME & Predictive Toxicology
Organization: Select Biosciences
Venue: Rey Juan Carlos I
|Event Date/Time: Apr 11, 2013||End Date/Time: Apr 12, 2013|
The 2013 ADME & Predictive Toxicology conference will report on the vital role ADME and Predictive Toxicology play in aiding successful drug candidate identification and design. Ensuring drugs make it to the market quicker, with higher hit rates and earlier indications of human toxicity issues is of the utmost importance and will be discussed at length here.
Our array of Keynote Speakers will give presentations on all areas of ADME/Tox backed up by a panel of experts speaking on highly relevant and “hot” topics such as Pharmacogenomics and Drug Safety, Genotoxicity and Toxicokinetic Modeling and ADME Optimisation for Drug Design/Discovery.
Running alongside the conference will be an exhibition covering the latest technological advances and associated services within these fields.
Also, co-located with our ADME & Predictive Toxicology conference will be our Nanomedicine meeting.
- ADME and Metabolomics
- ADME Optimisation for Drug Design/Discovery
- Genotoxicity and Toxicokinetic Modeling
- New Therapeutic Targets in Drug Design/Discovery
- Pharmacogenomics and Drug Safety
- Regulatory Issues in ADME
Magnus Ingelman-Sundberg, Professor/Head, Karolinska Institutet
Urs Meyer, Emeritus Professor, Biozentrum/University of Basel
Bernard Testa, Emeritus Professor, University Hospital Centre Lausanne
Head of Non-Clinical Development, UCB Pharma